Lo Riso, Pietro
Villa, Carlo Emanuele
Gasparoni, Gilles
Vingiani, Andrea
Luongo, Raffaele
Manfredi, Anna
Jungmann, Annemarie
Bertolotti, Alessia
Borgo, Francesca
Garbi, Annalisa
Lupia, Michela
Laise, Pasquale
Das, Vivek
Pruneri, Giancarlo
Viale, Giuseppe
Colombo, Nicoletta
Manzo, Teresa
Nezi, Luigi
Cavallaro, Ugo
Cacchiarelli, Davide
Walter, Jörn
Testa, Giuseppe
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG2014-15214, IG2017-20016, IG-14622)
EPIGEN Flagship Project of the Italian National Research Council
Ricerca Corrente from the Italian Ministry of Health
Fondazione Italiana per la Ricerca sul Cancro
Ricerca Finalizzata from the Italian Ministry of Health (PE-2016-02362551)
Fondazione Telethon
Giovanni Armenise-Harvard Foundation
European Research Council (759154)
Rita-Levi Montalcini program from MIUR
Fondazione Istituto Europeo di Oncologia-Centro Cardiologico Monzino
Article History
Received: 19 December 2019
Accepted: 30 September 2020
First Online: 30 October 2020
Ethics approval and consent to participate
: The study was conducted upon approval of the Ethics Committee of the European Institute of Oncology, Milan, following its standard operating procedures (“presa d’atto” 12 March 2014 and 24 July 2017) and performed in accordance with the Declaration of Helsinki. Fresh tissue samples were obtained upon informed consent from patients undergoing surgery at the Gynecology Division of the European Institute of Oncology. Only tissue samples from patients who have given informed consent to (i) the collection of samples for research purposes and their storage into the Biobank of the European Institute of Oncology and (ii) the transfer of samples to other research institutions for cancer research purposes have been used in this project. Collected personal data have been pseudonymized and have been stored and processed in compliance with the applicable data protection legislation, D. Lgs 196/2003 and, since 25 May 2018, Regulation (EU) 2016/679 (General Data Protection Regulation).
: Not applicable.
: Dr. Pasquale Laise is Director of Single-Cell Systems Biology at DarwinHealth, Inc., New York, NY, USA. The remaining authors declare that they have no competing interests.